Hemorheology in asymptomatic HIV-infected patients

Clinical Hemorheology and Microcirculation

Volumn 23, Issue 1, 2000, Pages 59-66

  Monsuez, Jean Jacques ^a   Dufaux, Jacques ^b   Vittecoq, Daniel ^a   Flaud, Patrice ^b   Vicaut, Eric ^c  

^a HÔPITAL PAUL BROUSSE   (France)

^b CNRS   (France)

^c HÔPITAL FERNAND WIDAL   (France)

Author keywords

AIDS; Erythrocyte aggregation; Hemorheology; Vascular biology

Indexed keywords

CD4 ANTIGEN; DIDANOSINE; HEMOGLOBIN; IMMUNOGLOBULIN; INDINAVIR; LAMIVUDINE; RITONAVIR; SAQUINAVIR; ZIDOVUDINE;

ADULT; ARTICLE; BLOOD RHEOLOGY; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE AGGREGATION; FEMALE; HELPER CELL; HEMATOCRIT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; SHEAR RATE;

ADULT; ANTI-HIV AGENTS; BLOOD SEDIMENTATION; CASE-CONTROL STUDIES; ERYTHROCYTE AGGREGATION; FEMALE; HEMORHEOLOGY; HIV INFECTIONS; HUMANS; KINETICS; LINEAR MODELS; MALE; MIDDLE AGED; RISK FACTORS; STRESS, MECHANICAL;

EID: 0034521842     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. N. A. Yunis and V.E. Stone, Cardiac Manifestations of HIV/AIDS. A review of disease spectrum and clinical management, J. AIDS 18 (1998), 145-154.
2. J.J. Monsuez, E.L. Kinney, D. Vittecoq, M. Kitzis, W. Rozenbaum, M.F. D'agay, M. Wolff, C. Marche, M. Janier and I. Gorin, Comparaison among acquired immune deficiency syndrome patients with and without clinical evidence of cardiac disease, Am. J. Cardiol. 62 (1988), 1311-1313.
3. P.A. Heidenreich, M.A. Eisenberg, L.L. Kee, C.A. Somelofski, H. Hollander, N.B. Schiller and M.D. Cheitlin, Pericardial effusion in AIDS: incidence and survival, Circulation 92 (1995), 3229-3234.
4. S.E. Lipshultz, K.A. Easley, J. Orav, S. Kaplan, T.J. Starc, T. Bricker, W.W. Lai, D.S. Moodie, K.Mc Intosh, M.D. Schluchter and S.D. Colan, Left ventricular structure and function in children infected with human immunodeficiency virus, Circulation 97 (1998), 1246-1256.
5. Rui-Juan Xiu, Cheng Jun and O. Berglund, Microcirculatory disturbances in AIDS patients, Microvasc. Res. 42 (1991), 151-159.
6. P.J.M. Best, W.D. Edwards, D.R. Holmes and A. Lerman, Unique coronary arteriopathy associated with human immunodeficiency virus, J. Am. Coll. Cardiol. 31 (1997), 272A.
7. C. Rainier, D.T. Kawanishi and A.N. Chandraratna, Changes in blood rheology in patients with stable angina pectoris as a result of coronary artery disease, Circulation 76 (1987), 15-20.
8. S. Forconi, D. Pieragalli, M. Guerrini and T. Di Perri, Hemorheology and peripheral arterial diseases, Clin. Hemorheol. 7 (1987), 145.
9. J.H. Wood and D.B. Kee, Hemorheology of the cerebral circulation in stroke, Stroke 16 (1985), 765-772.
10. C. Le Devehat, T. Khodabandehlou and M. Vimeux, Relationship between hemorheological and microcirculatory abnormalities in diabetes mellitus, Diabet. Metab. 20 (1994), 401-404.
11. S.M. Razavian, M. Del Pino, A. Simon and J. Levenson, Increase in erythrocyte disaggregation shear stress in hypertension, Hypertension 20 (1992), 247-252.
12. Revision of the CDC case surveillance case definition for acquired immunodeficiency syndrome, Morbid Mortal Week Rep. 36 (Suppl. 1S) (1987), 1S-5S.
13. P. Snabre, M. Bitbol and P. Mills, Cell disaggregation behavior in shear flow, Biophysical. J. 51 (1987), 795-807.
14. J.F. Stoltz, Perspectives en hémorhéologie clinique, J. Mal. Vasc. 21 (1996), 7-15.
15. V.V. Joshi, B. Powel and E. Conner, Arteriopathy in children with acquired immune deficiency syndrome, Pediatr. Pathol. 7 (1987), 261-275.
16. P. Paton, A. Tabib, R. Loire and R. Tete, Coronary artery lesions and human immunodeficiency virus infection. Res. Virol. 144 (1993), 225-231.
17. C. Zietz, B. Hotz, M. Sturzl, E. Rauch, R. Penning and U. Lohrs, Aortic endothelium in HIV-1 infection: chronic injury, activation and increased leucocyte adherence, Am. J. Pathol. 149 (1996), 1887-1898.
18. S. Dhawan, B.S. Weeks, C. Soderland, H.W. Schnapper, L.A. Toro, S.P. Asthana, I.K. Hewlett, W.G. Stetler-Stevenson, S.S. Yamada and K.M. Yamada, HIV-1 infection alters monocyte interaction with human microvascular endothelial cells, J. Immunol. 154 (1995), 422-432.
19. N. Maeda, M. Sekiya, K. Kameda and T. Shiga, Effect of immunoglobulin preparations on the aggregation of human erythrocytes, Eur. J. Clin. Invest. 16 (1986), 184-191.
20. N. Maeda, M. Seike, S. Kume, T. Takaku and T. Shiga, Fibrinogen-induced erythrocyte aggregation: erythrocyte-binding site in the fibrinogen molecule, Biochim. Biophys. Acta 904 (1987), 81-91.
21. G. Potron, B. Pignon, J.L. Mailliot and P. Nguyen, Erythrocyte aggregation and sedimentation: influence of acute phase mediators, in: Hemorheologie et Agrégation Erythrocytaire, Technique et Documentation, Lavoisier, 1994, pp. 51-56.
22. B. Paul, S. Houston and A.S. Latif, HIV infection associated with the plasma hyperviscosity syndrome: a report of two fatal cases, AIDS 4 (1990), 1302-1304.
23. K. Henry, H. Melroe, J. Huebsch, J. Hermundson, C. Levine, L. Swensen and J. Daley, Severe premature coronary artery disease with protease inhibitors. Lancet 351 (1998), 1328.
24. D. Vittecoq, L. Escaut and J.J. Monsuez, Vascular complications associated with use of HIV protease inhibitors, Lancet 351 (1998), 1959.
25. R. Sorelle, Vascular and lipid syndromes in selected HIV-infected patients, Circulation 98 (1998), 829-830.
26. K. Miller, E. Jones, J. Yanovsky, R. Shankar, I. Feuerstein and J. Falloon, Visceral-abdominal-fat associated with use of indinavir. Lancet 351 (1998), 871-875.
27. A. Carr, K. Samaras, D.J. Chisholm and D.A. Cooper, Pathogenesis of HIV-1 protease inhibitor-associated peripheral lipodystrophy, hyperlipidemia and insulin resistance, Lancet 352 (1998), 1881-1883.
28. R. Walli, F.D. Goebel and T. Demant, Impaired glucose tolerance and protease inhibitors, Ann. Intern. Med. 125 (1998), 837-838.
29. S. Muller, O. Ziegler, M. Donner, P. Drouin and J.F. Stoltz, Rheological properties and membrane fluidity of red blood cells and platelets in primary hyperlipoproteinemia, Atherosclerosis 83 (1990), 231-237.